Document Detail

Autophagy modulation as a potential therapeutic target for diverse diseases.
MedLine Citation:
PMID:  22935804     Owner:  NLM     Status:  MEDLINE    
Autophagy is an essential, conserved lysosomal degradation pathway that controls the quality of the cytoplasm by eliminating protein aggregates and damaged organelles. It begins when double-membraned autophagosomes engulf portions of the cytoplasm, which is followed by fusion of these vesicles with lysosomes and degradation of the autophagic contents. In addition to its vital homeostatic role, this degradation pathway is involved in various human disorders, including metabolic conditions, neurodegenerative diseases, cancers and infectious diseases. This article provides an overview of the mechanisms and regulation of autophagy, the role of this pathway in disease and strategies for therapeutic modulation.
David C Rubinsztein; Patrice Codogno; Beth Levine
Related Documents :
22084854 - Communitarianism and the ethics of communicable disease: some preliminary thoughts.
22050474 - Etiopathological aspects of achalasia: lessons learned with hirschsprung's disease.
21241384 - Use of biological molecules in the treatment of inflammatory bowel disease.
8004794 - Non-expression of von hippel-lindau phenotype in an obligate gene carrier.
6497464 - Antibodies to peptidoglycan in patients with spondylarthritis: a clue to disease aetiol...
16391474 - Csf biomarkers for alzheimer's disease: levels of beta-amyloid, tau, phosphorylated tau...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Nature reviews. Drug discovery     Volume:  11     ISSN:  1474-1784     ISO Abbreviation:  Nat Rev Drug Discov     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-08-31     Completed Date:  2012-11-05     Revised Date:  2014-02-24    
Medline Journal Info:
Nlm Unique ID:  101124171     Medline TA:  Nat Rev Drug Discov     Country:  England    
Other Details:
Languages:  eng     Pagination:  709-30     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Autophagy / drug effects*,  physiology
Communicable Diseases / drug therapy,  epidemiology
Drug Delivery Systems / methods*,  trends
Neurodegenerative Diseases / drug therapy,  epidemiology
Pharmaceutical Preparations / administration & dosage*
Signal Transduction / drug effects*,  physiology
Grant Support
089703//Wellcome Trust; 095317//Wellcome Trust; G0600194//Medical Research Council; MC_G1000734//Medical Research Council; R01 CA109618/CA/NCI NIH HHS; R01 CA109618/CA/NCI NIH HHS; U54 AI057156/AI/NIAID NIH HHS; U54AI057156/AI/NIAID NIH HHS; //Medical Research Council; //Wellcome Trust
Reg. No./Substance:
0/Pharmaceutical Preparations

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Leptin revisited: its mechanism of action and potential for treating diabetes.
Next Document:  Cochlear Implantation in Patients Profoundly Deafened After Head Injury.